Scinai Immunotherapeutics Ltd
SCNI1.525USD
+0.055+3.74%
시장 운영 시간 （ET）시세는 15분 지연됩니다
1.30M시가총액
0.35P/E TTM
자세한 내용은 Scinai Immunotherapeutics Ltd 회사
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
회사 정보
종목 코드 SCNI
회사 이름Scinai Immunotherapeutics Ltd
상장일Jun 07, 2007
CEOMr. Amir Reichman
직원 수31
유형Depository Receipt
회계 연도 종료Jun 07
주소Jerusalem Biopark, 2Nd Floor
도시JERUSALEM
증권 거래소NASDAQ Capital Market Consolidated
국가Israel
우편 번호00000
전화97289302529
웹사이트https://www.scinai.com/
종목 코드 SCNI
상장일Jun 07, 2007
CEOMr. Amir Reichman
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
8.08K
+236.54%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
1.27K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
276.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
+51.52%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-26.47%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
+51.52%
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Mr. Joshua Phillipson
Mr. Joshua Phillipson
Investor Relations
Investor Relations
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
8.08K
+236.54%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
1.27K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
276.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
+51.52%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-26.47%
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Wed, May 28
마지막 업데이트: Wed, May 28
주주
주주 유형
주주
주주
비율
Yorkville Advisors Global, LP.
10.93%
LCK JNK 1 LLC
9.47%
Stone (Daniel E)
7.32%
Armistice Capital LLC
5.25%
Abalone Asset Management Ltd.
4.99%
Other
62.04%
주주
주주
비율
Yorkville Advisors Global, LP.
10.93%
LCK JNK 1 LLC
9.47%
Stone (Daniel E)
7.32%
Armistice Capital LLC
5.25%
Abalone Asset Management Ltd.
4.99%
Other
62.04%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
14.34%
Corporation
9.47%
Individual Investor
8.75%
Investment Advisor
6.93%
Hedge Fund
5.25%
Research Firm
0.02%
Other
55.24%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
32
381.87K
44.77%
+269.77K
2025Q1
34
424.61K
49.78%
+268.71K
2024Q4
29
225.02K
26.38%
+113.05K
2024Q3
33
172.68K
20.39%
+41.77K
2024Q2
34
145.50K
9.79%
-4.50K
2024Q1
37
164.38K
100.97%
+8.82K
2023Q4
39
169.63K
48.24%
+28.24K
2023Q3
42
134.35K
45.97%
+54.60K
2023Q2
41
94.79K
37.87%
-787.00
2023Q1
43
111.61K
43.64%
+31.95K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Yorkville Advisors Global, LP.
93.27K
10.93%
+93.27K
--
Mar 24, 2025
LCK JNK 1 LLC
80.76K
9.47%
+80.76K
--
Feb 09, 2025
Stone (Daniel E)
62.40K
7.32%
--
--
Dec 31, 2024
Armistice Capital LLC
44.80K
5.25%
+44.80K
--
Sep 30, 2024
Abalone Asset Management Ltd.
42.54K
4.99%
+24.54K
+136.35%
Jun 30, 2024
Sabby Management, LLC
29.05K
3.41%
+29.05K
--
Dec 31, 2024
UBS Financial Services, Inc.
14.93K
1.75%
-8.56K
-36.43%
Mar 31, 2025
Reichman (Amir)
8.08K
0.95%
+5.68K
+236.54%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
1.57K
0.18%
-86.00
-5.20%
Mar 31, 2025
Ben-Yedidia (Tamar)
1.35K
0.16%
+1.35K
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
SPDR Portfolio Developed World ex-US ETF
0%
SPDR Portfolio Developed World ex-US ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
Nov 23, 2022
Merger
10<1
Nov 23, 2022
Merger
10<1
날짜
유형
비율
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
May 06, 2024
Merger
10<1
Nov 23, 2022
Merger
10<1
Nov 23, 2022
Merger
10<1
Nov 23, 2022
Merger
10<1
Nov 23, 2022
Merger
10<1
